Registered number
08963585
TRV Pharma Limited
Filleted Accounts
31 March 2023
TRV Pharma Limited
Registered number: 08963585
Balance Sheet
as at 31 March 2023
Notes 2023 2022
£ £
Fixed assets
Tangible assets 3 550 734
Current assets
Cash at bank and in hand 91,595 32,443
Creditors: amounts falling due within one year 4 (69,027) (26,193)
Net current assets 22,568 6,250
Net assets 23,118 6,984
Capital and reserves
Called up share capital 1 1
Profit and loss account 23,117 6,983
Shareholders' funds 23,118 6,984
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Gnaneswar Vadapalli
Director
Approved by the board on 19 July 2023
TRV Pharma Limited
Notes to the Accounts
for the year ended 31 March 2023
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery 25% on reducing balance
Fixtures, fittings, tools and equipment 25% on reducing balance
2 Employees 2023 2022
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2022 1,648
At 31 March 2023 1,648
Depreciation
At 1 April 2022 914
Charge for the year 184
At 31 March 2023 1,098
Net book value
At 31 March 2023 550
At 31 March 2022 734
4 Creditors: amounts falling due within one year 2023 2022
£ £
Trade creditors 340 -
Corporation tax 10,865 6,801
Other taxes and social security costs (929) (656)
Other creditors 58,751 20,048
69,027 26,193
5 Other information
TRV Pharma Limited is a private company limited by shares and incorporated in England. Its registered office is:
29 Academy Drive
Gillingham
Kent
England
ME7 3EG
TRV Pharma Limited 08963585 false 2022-04-01 2023-03-31 2023-03-31 VT Final Accounts April 2022 Gnaneswar Vadapalli No description of principal activity 08963585 2021-04-01 2022-03-31 08963585 core:WithinOneYear 2022-03-31 08963585 core:ShareCapital 2022-03-31 08963585 core:RetainedEarningsAccumulatedLosses 2022-03-31 08963585 2022-04-01 2023-03-31 08963585 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 08963585 bus:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 08963585 bus:Director40 2022-04-01 2023-03-31 08963585 core:PlantMachinery 2022-04-01 2023-03-31 08963585 countries:England 2022-04-01 2023-03-31 08963585 bus:FRS102 2022-04-01 2023-03-31 08963585 bus:FullAccounts 2022-04-01 2023-03-31 08963585 2023-03-31 08963585 core:WithinOneYear 2023-03-31 08963585 core:ShareCapital 2023-03-31 08963585 core:RetainedEarningsAccumulatedLosses 2023-03-31 08963585 core:PlantMachinery 2023-03-31 08963585 2022-03-31 08963585 core:PlantMachinery 2022-03-31 iso4217:GBP xbrli:pure